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RIG-I and MDA5 have emerged as key cytosolic
sensors for the detection of RNA viruses and
lead to antiviral interferon (IFN) production. Recent
studies have highlighted the importance of post-
translational modifications for controlling RIG-I
antiviral activity. However, the regulation of MDA5
signal-transducing ability remains unclear. Here, we
show that MDA5 signaling activity is regulated by
a dynamic balance between phosphorylation and
dephosphorylation of its caspase recruitment do-
mains (CARDs). Employing a phosphatome RNAi
screen, we identified PP1a and PP1g as the primary
phosphatases that are responsible for MDA5 and
RIG-I dephosphorylation and that lead to their activa-
tion. Silencing of PP1a and PP1g enhanced RIG-I
and MDA5 CARD phosphorylation and reduced anti-
viral IFN-b production. PP1a- and PP1g-depleted
cells were impaired in their ability to induce IFN-
stimulated gene expression, which resulted in
enhanced RNA virus replication. This work identifies
PP1a and PP1g as regulators of antiviral innate
immune responses to various RNA viruses, including
influenza virus, paramyxovirus, dengue virus, and
picornavirus.
INTRODUCTION
RNA helicases of the RIG-I-like receptor family play key roles in
innate immunity to invading viruses. Specifically, RIG-I and
MDA5 sense viral RNA in the cytosol and subsequently bind
through their N-terminal caspase recruitment domains (CARDs)
to the signaling adaptor MAVS (also called VISA, IPS-1, or
CARDIF); this binding triggers antiviral innate immune responses,
resulting in the production of type I interferons (IFNs) and proin-
flammatory cytokines (Barbalat et al., 2011; Loo and Gale,2011; Meylan et al., 2006). Despite their highly homologous
structure, comprising two N-terminal CARDs, a DExD/H box
RNA helicase, and a C-terminal domain (CTD), RIG-I and MDA5
sense distinct subsets of RNA viruses (Nakhaei et al., 2009).
Whereas RIG-I antiviral activity is directed against paramyxo-
viruses, influenza virus, vesicular stomatitis virus, and hepatitis
C virus, MDA5 primarily senses picornaviruses (Kato et al.,
2006; Loo et al., 2008; Sumpter et al., 2005). In addition, it has
been recently shown that MDA5 is crucial for the host defense
against paramyxoviruses in vivo (Gitlin et al., 2010). Furthermore,
both RIG-I and MDA5 function redundantly in the detection of
dengue virus (DenV) and West Nile virus (Loo et al., 2008).
Because a premature or overzealous innate immune response
would be detrimental to the host, innate immune sensing and
antiviral signal transduction must be tightly controlled. On the
other hand, upon viral infection, the rapid upregulation of IFN
and proinflammatory cytokines is crucial for an effective antiviral
response. Several positive and negative regulatory mechanisms
for controlling RIG-I innate immune signaling have been
described. RIG-I expression levels are rapidly increased upon
exposure to IFN, providing a positive-feedback mechanism for
the amplification of the innate immune response upon virus
infection. On the other hand, virus-induced upregulation of
a short RIG-I splice variant, which acts in a dominant-negative
manner, provides a negative-feedback mechanism of RIG-I
antiviral signaling (Gack et al., 2008). Posttranslational modifica-
tions add another level of complexity to the regulation of RIG-I.
RIG-I activity is negatively regulated by K48-linked ubiquitina-
tion, thereby inducing degradation of RIG-I by the proteasome
(Arimoto et al., 2007). In contrast, K63-linked ubiquitination of
the RIG-I CARDs, as well as its CTD, is critical for RIG-I to elicit
antiviral activity (Gack et al., 2007; Oshiumi et al., 2009). Specif-
ically, the ubiquitin E3 ligase TRIM25 ubiquitinates K172 in the
CARD2 of RIG-I, which is essential for the efficient interaction
of RIG-I with MAVS and thus for antiviral signal transduction
(Gack et al., 2007). Notably, influenza virus employs its nonstruc-
tural protein 1 (NS1) to subvert RIG-I ubiquitination-dependent
signaling by binding to and inhibiting TRIM25 (Gack et al.,
2009). Furthermore, we have recently shown that Ser-Thr phos-
phorylation of the RIG-I tandem CARD keeps RIG-I inactive andImmunity 38, 437–449, March 21, 2013 ª2013 Elsevier Inc. 437
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uninfected cells, RIG-I is robustly phosphorylated at S8 and
T170, which inhibits RIG-I binding to TRIM25 and thus RIG-I
CARD ubiquitination, MAVS binding, and type I IFN induction
(Gack et al., 2010; Maharaj et al., 2012). In striking contrast to
the regulatory mechanisms controlling RIG-I signaling activity,
those controlling MDA5 signaling activity remain elusive.
Here, we not only show that MDA5-mediated signaling is
regulated by a dynamic balance between phosphorylation and
dephosphorylation of its N-terminal CARDs but also identify
the phosphatases PP1a and PP1g as essential activators of
both RIG-I and MDA5 signal transduction.
RESULTS
The N-Terminal CARDs of MDA5 Are Phosphorylated
To define the molecular mechanisms that regulate MDA5
signal-transducing ability, we sought to identify posttransla-
tional modifications of the N-terminal 2CARD of MDA5 by using
a mammalian glutathione S-transferase (GST) fusion construct.
Purified GST-MDA5(2CARD) was then analyzed by liquid
chromatography coupled with tandem mass spectrometry (Fig-
ure 1A and Figure S1A, available online). This showed that the
MDA5(2CARD) carries phosphorylations at Ser-88 (S88) and
Ser-104 (S104), located in the first CARD and short CARD-
CARD linker region, respectively (Figures 1A and 1B and
Figures S1B and S1C). To determine the role of S88 and
S104 phosphorylation in the regulation of MDA5 signaling
activity, we replaced S88 and S104 individually with alanine or
arginine (S88A/R or S104A/R) to mimic nonphosphorylation or
with aspartic or glutamic acid (S88D/E or S104D/E) to mimic
constitutive phosphorylation (Figure 1C). Wild-type (WT)
and mutant forms of GST-MDA5(2CARD) were then tested
for their signal-transducing abilities in an IFN-b and NF-lB
promoter-activation assay. As shown in Figure 1C, no
phosphorylation-state-dependent effect was observed for the
GST-MDA5(2CARD) S104 mutants: whereas S104A, S104E, and
S104R mutants exhibited less ability to induce IFN-b or NF-lB
promoter activation than did the WT, the S104D mutant showed
an increase in signaling activity. Strikingly, compared with WT
MDA5(2CARD), GST-MDA5(2CARD) phosphomimetic S88D
and S88E mutants exhibited a near-complete loss of down-
stream signaling, whereas GST-MDA5(2CARD) S88A and S88R
mutants activated the IFN-b and NF-lB promoter at levels
similar to those of the WT (Figure 1C).
To demonstrate the in vivo phosphorylations of
MDA5 at S88 and S104, we used the 15 aa peptides
[80VEALRRTG(p)SPLAARY94] and [98ELTDLP(p)SPSFENAHD112],
containing phosphorylated S88 and S104, respectively, to
generate the phosphorylation state-specific pSer-88-MDA5
and pSer-104-MDA5 antibodies, respectively. Both antibodies
strongly and specifically reacted with WT GST-MDA5(2CARD),
but not with the S88A or S104A mutant (Figures S1D and S1E).
Furthermore, whereas both S88 and S104 phosphorylations of
GST-MDA5(2CARD) and Flag-MDA5 were readily detectable in
mock-treated cells, treatment with the Ser-Thr phosphatase
inhibitor calyculin A further enhanced the S88 phosphorylation
levels but had only a minimal effect on the S104 phosphorylation
of MDA5 (Figure 1D and Figure S1F). This suggests that MDA5438 Immunity 38, 437–449, March 21, 2013 ª2013 Elsevier Inc.phosphorylation at S88, but not at S104, is tightly controlled by
phosphatase-dependent dephosphorylation.
We next monitored the S88 and S104 phosphorylation levels
of exogenous MDA5 under normal conditions or in cells infected
with encephalomyocarditis virus (EMCV), a picornavirus sensed
byMDA5, or transfectedwith the dsRNA analog polyinosine-pol-
ycytidylic acid [poly(I:C)] (Figures 1E and 1F). This showed that
both S88 and S104 phosphorylations of MDA5 are readily
detectable under normal conditions. Remarkably, whereas the
phosphorylation levels of MDA5 at S104 did not change upon
EMCV infection or poly(I:C) transfection, the MDA5 S88 phos-
phorylation markedly decreased upon virus infection or dsRNA
stimulation (Figures 1E and 1F). This decline in S88 phosphory-
lation was specific to MDA5 stimulation by virus infection or
dsRNA, given that IFN-b treatment did not affect the S88 phos-
phorylation levels of MDA5 (Figure 1E). Consistent with our data
on exogenously expressed MDA5, endogenous MDA5 was
robustly phosphorylated at S88 in uninfected cells, and this
phosphorylation markedly declined upon EMCV infection (Fig-
ure 1G). Taken together, these results indicate that MDA5
undergoes robust phosphorylation in its N-terminal CARDs
under normal conditions and that phosphorylation and dephos-
phorylation specifically at S88 are critical for regulating MDA5
signaling activity.
Phosphorylation of MDA5 at S88 Inhibits Its
Downstream Signaling
To corroborate the S88 phosphorylation of the 2CARD of MDA5,
we tested the basal and poly(I:C)-stimulated activity of full-length
WT MDA5 and MDA5 S88 mutants in an IFN-b promoter-
activation assay (Figure 2A). Consistent with previous reports
(Andrejeva et al., 2004; Saito et al., 2007), ectopic WT MDA5
readily activated the IFN-b promoter in mock-treated cells, and
its activation was further enhanced by poly(I:C) stimulation.
Whereas the MDA5 S88A mutant exhibited an IFN-b promoter
activation stronger than that of WT MDA5, the phosphomimetic
MDA5 S88E and S88D mutants did not activate the IFN-b
promoter with or without poly(I:C) stimulation (Figure 2A).
MDA5 binding to the CARD of the downstream adaptor MAVS
(also known as VISA, IPS-1, or CARDIF) is essential for MDA5
to elicit an IFN response (Kawai et al., 2005; Meylan et al.,
2005; Seth et al., 2005; Xu et al., 2005). Thus, we next tested
WT GST-MDA5(2CARD) and its S88 mutants for their binding
to the CARD of MAVS (Figure 2B). Whereas WT GST-
MDA5(2CARD) and its S88A mutant bound strongly to Flag-
tagged MAVS-CARD-proline-rich domain (PRD), the S88D and
S88E mutants showed a complete loss of MAVS-CARD interac-
tion (Figure 2B). Furthermore, thesemutants were tested for their
ability to induce the dimerization and nuclear translocation of IFN
regulatory factor 3 (IRF3), anessential transcription factor for type
I IFN induction (Honda et al., 2006) (Figures 2C and 2D).WTGST-
MDA5(2CARD) and its S88A mutant efficiently induced IRF3
dimerization and nuclear translocation; in contrast, no IRF3
dimerization or nuclear localization was detected in cells trans-
fectedwith the phosphomimetic mutants S88D and S88E (Figures
2C and 2D). Moreover, increasing amounts of the Flag-MDA5
S88D mutant potently suppressed the poly(I:C)-induced IFN-b
promoter activation in a dominant-negative manner, whereas
the Flag-MDA5 S88A mutant robustly increased the IFN-b
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Figure 1. Phosphorylation of the MDA5 CARDs
(A) MDA5 domain structure and amino acid sequence of the CARDs. Phosphorylation sites identified by mass spectrometry are highlighted in red. The following
abbreviation is used: CTD, C-terminal domain.
(B) Tandem mass spectra of tryptic phosphopeptides RTGpS88PLAAR and DLPpS104PSFENAH identified phosphorylation sites at S88 and S104, respectively.
b- and y-ion designations are shown (Aebersold and Goodlett, 2001).
(C) GST, WT GST-MDA5(2CARD), and the indicated GST-MDA5(2CARD) mutants were expressed together with IFN-b or NF-lB luciferase and constitutive
b-galactosidase (b-gal) expressing pGK-b-gal in HEK293T cells. Values for luciferase and b-gal were determined 48 hr after transfection. The results are
expressed as means ± SD (n = 3). Whole-cell lysates (WCLs) were used for immunoblotting (IB) with GST and actin antibodies.
(D) Detection of S88 and S104 phosphorylations of MDA5 in vivo with phosphospecific pS88-MDA5 and pS104-MDA5 antibodies. HEK293T cells were mock
treated or treated with calyculin A (Cal A) 48 hr after transfection with GST-MDA5(2CARD). WCLs were subjected to GST pulldown (GST-PD), followed by IB with
the indicated antibodies. WCLs were further used for IB with phosphothreonine (anti-pThr) and actin antibodies.
(E and F) HEK293T cells transfected with Flag-MDA5 were either mock treated, infected with EMCV (multiplicity of infection [MOI] 0.5) for 3 hr, transfected with
5 mg/ml poly(I:C), or treated with 1,000 U/ml IFN-b for 20 hr. WCLs were subjected to immunoprecipitation (IP) with Flag antibody and subsequent IB with
antibodies against pS88-MDA5 (E) or pS104-MDA5 (F) and Flag (E and F).
(G) HEK293T cells were either mock infected or infected with EMCV (MOI 0.5) for 3 hr. WCLs were used for IP with MDA5 antibody, and IB followed.
See also Figure S1.
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Activation of RIG-I and MDA5 Signaling by PP1promoter activation induced by poly(I:C) (Figure 2E). Finally,
correlatedwith their signal-transducing abilities in human embry-
onic kidney (HEK) 293T cells, ectopically expressedWT andS88A
mutant MDA5 in Mda5-deficient (Ifih1/) mouse embryonic
fibroblasts (MEFs) detectably induced IFN-b production in
mock-treated cells, whereas S88E and S88D MDA5 mutants did
not induce any IFN-b (Figure 2F). Furthermore, poly(I:C) transfec-
tion ofMEFs expressingWTorS88AMDA5, but not of cells recon-
stitutedwith S88E or S88DMDA5, enhanced the IFN-b production
to significantly higher levels than that of vector-complementedMEFs (Figure 2F). These results indicate that whereas phosphor-
ylation of MDA5 at S88 suppresses the MDA5 interaction with
MAVS and thus MDA5 downstream signaling, phosphatase-
dependent dephosphorylation of MDA5 at S88 is necessary for
its ability to induce an antiviral IFN response.
A Functional Screen Identifies PP1a and PP1g as
Activators of MDA5 and RIG-I Signal Transduction
To identify the phosphatase responsible for MDA5 S88 dephos-
phorylation and hence activation, weperformed a screen utilizingImmunity 38, 437–449, March 21, 2013 ª2013 Elsevier Inc. 439
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Figure 2. MDA5 Phosphorylation at S88 Inhibits Its Downstream Signaling, whereas S88 Dephosphorylation Is Required for Optimal MDA5
Activity
(A) Vector, Myc-tagged WT MDA5, or MDA5 mutants together with IFN-b luciferase and pGK-b-gal were transfected into HEK293T cells. Cells were either mock
treated or transfected with 0.1 mg/ml poly(I:C) 24 hr after transfection. Luciferase and b-gal activity was determined 20 hr later. The results are expressed as
means ± SD (n = 3). Protein expressions were determined by IB.
(B) HEK293T cells were transfected with MAVS-CARD-PRD-Flag together with GST or GST-MDA5(2CARD) constructs. WCLs were subjected to GST-PD.
(C) At 48 hr after transfection with Flag-IRF3 and GST or GST-MDA5(2CARD) fusion constructs, WCLs of HEK293T cells were subjected to native PAGE, followed
by IB with Flag antibody. WCLs were also used for SDS-PAGE, followed by IB with GST and Flag antibodies.
(D) HEK293T cells were transfectedwith GST,WTGST-MDA5(2CARD), or the indicated GST-MDA5(2CARD)mutants and IRF3-EGFP. Cells were stained for GST
(red) and imaged by confocal microscopy 48 hr later.
(E) The MDA5 S88D mutant inhibits the poly(I:C)-induced IFN-b promoter activation. HEK293T cells were transfected with vector or increasing amounts of the
Flag-tagged MDA5 S88D or S88A mutant together with IFN-b luciferase and pGK-b-gal. Cells were either mock treated or cotransfected with 3 mg/ml poly(I:C).
Luciferase activity was determined 48 hr later as described in Figure 1C. The results, expressed as means ± SD (n = 2), are representative of three independent
experiments.
(F) Mda5-deficient (Ifih1/) MEFs were transfected with vector, WT MDA5, or MDA5 mutants. Cells were either mock treated or transfected with 0.1 mg/ml
poly(I:C) 24 hr after plasmid transfection. IFN-b production in the supernatant wasmeasured by ELISA 20 hr later. The results are expressed asmeans ± SD (n = 3).
The following abbreviation is used: ND, not detectable.
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Activation of RIG-I and MDA5 Signaling by PP1the Dharmacon phosphatome small interfering RNA (siRNA)
library comprising siRNA pools targeting 257 human phospha-
tases, including Ser-Thr phosphatases, Tyr phosphatases, and
Ser-Thr-Tyr dual-specificity phosphatases. We performed two
parallel screens to determine the impact of phosphatase
silencing on the IFN-b promoter activation induced by GST-
MDA5(2CARD) or full-length MDA5. Compared to transfection
of nontargeting control siRNA, depletion of various phospha-
tase-encoding genes led to amarkeddecrease inMDA5-induced
IFN-b promoter activation (Figure 3A and data not shown), and
the nine strongest and/or overlapping hits that suppressed the
MDA5(2CARD)- and full-length-MDA5-mediated IFN-b promoter
activationwere then cloned into an eukaryotic expression vector.440 Immunity 38, 437–449, March 21, 2013 ª2013 Elsevier Inc.The effect of ectopic expression of candidate phosphatases on
MDA5(2CARD)- and full-length-MDA5-induced IFN-b promoter
activation was then examined by luciferase assay (Figure 3B
and Figure S2A). Strikingly, exogenous expression of phospho-
protein phosphatase 1 a (PP1a) and PP1g specifically and
strongly augmented the IFN-b transcriptional activation induced
by full-length MDA5 or MDA5(2CARD), whereas other phospha-
tases had no or minimal effects (Figure 3B and Figure S2A).
Mammals encode three PP1 isoforms (PP1a, PP1b, and PP1g)
that are ubiquitously expressed and implicated in the regulation
of various cellular processes, including glycogen metabolism,
brain function, and muscle relaxation (Cohen, 2002). We thus
tested the effect of PP1a, PP1b, or PP1g expression on MDA5
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Figure 3. Identification of PP1a and PP1g as Critical Regulators of MDA5 and RIG-I Signal-Transducing Activities
(A) Identified candidate phosphatases from a siRNA-based screen. HEK293T cells were transfected with GST-MDA5(2CARD) together with siRNA pools specific
to one of 257 human phosphatases, as well as IFN-b luciferase and pGK-b-gal. Luciferase and b-gal activities were determined 48 hr after transfection. Results
of the top nine siRNA hits, as well as of the siRNA specific to IRF3 (positive control), are shown. Activation by GST-MDA5(2CARD) upon cotransfection of
a nontargeting control siRNA (si.C) was set to 100%.
(B) Flag-MDA5 was cotransfected with the indicated candidate phosphatases together with IFN-b luciferase and pGK-b-gal. Luciferase and b-gal activities were
determined 48 hr after transfection. The results are expressed as means ± SD (n = 3).
(C) Flag-MDA5 was transfected together with increasing amounts of hemagglutinin (HA)-tagged PP1a, PP1b, or PP1g and IFN-b luciferase and pGK-b-gal. Lucif-
eraseandb-gal activitiesweremeasured48hr after transfection. The results, expressedasmeans±SD (n= 2), are representative of three independent experiments.
(D and E) HEK293T cells were transfected with GST or GST-MDA5(2CARD) together with IFN-b (D) or NF-lB (E) luciferase and pGK-b-gal, as well as nontargeting
control siRNA (si.C) or siRNAs specific to PP1a, PP1b, PP1g, or IRF3 (control). Luciferase and b-gal activities were determined 48 hr later. The results are
expressed as means ± SD (n = 3).
(F and G) HEK293T cells, transfected with IFN-b luciferase, pGK-b-gal, and the indicated siRNAs, were either cotransfected with GST or GST-RIG-I(2CARD)
(F) or infected with SeV (5 HAU/ml) for 14 hr (G). Luciferase and b-gal activities were determined. The results are expressed as means ± SD (n = 3).
See also Figure S2.
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Activation of RIG-I and MDA5 Signaling by PP1signal transduction (Figure 3C). Increasing amounts of PP1a or
PP1g, but not PP1b, robustly enhanced the IFN-b promoter acti-
vation triggered by MDA5 (Figure 3C). Notably, exogenous
expression of PP1a or PP1g did not have any effect on the
IFN-b promoter activation induced by exogenous MAVS (Fig-
ure S2B), reinforcing that PP1a and PP1g act specifically at the
level of MDA5 and not downstream of it. Conversely, specific
silencing of endogenous PP1a or PP1g, but not PP1b, strongly
inhibited MDA5(2CARD)-mediated IFN-b and NF-lB transcrip-
tional activation, and depletion of endogenous PP1a and PP1g
was confirmed by immunoblotting (Figures 3D and 3E and
Figures S2C and S2D). To exclude off-target effects, we sepa-
rately retested the four unique siRNAs from each pool, as well
as one additional siRNA specifically targeting PP1a or PP1g(Figures S2E and S2F). This showed that all five distinct
siRNAs targeting PP1a or PP1g reduced the MDA5(2CARD)-
induced IFN-b promoter activation, and the levels of depletion
correlated with their suppressive effect on the IFN-b promoter
(Figures S2E and S2F).
Our previous work demonstrated that RIG-I CARD phos-
phorylation at S8 and T170 suppresses the TRIM25-mediated
K63-linked ubiquitination of RIG-I and thereby prevents RIG-I
downstream signaling (Gack et al., 2010; Maharaj et al., 2012;
Nistal-Villa´n et al., 2010). Our study also indicated that
stimulus-induced dephosphorylation of the RIG-I CARDs is
essential for RIG-I to initiate downstream signaling. We thus
postulated that PP1a and PP1g might be common activators
of both MDA5 and RIG-I by inducing dephosphorylation of theirImmunity 38, 437–449, March 21, 2013 ª2013 Elsevier Inc. 441
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Figure 4. PP1a and PP1g Interact with RIG-I and MDA5, Leading to Their CARD Dephosphorylation
(A) WCLs of HEK293T cells, transfectedwith Flag-taggedMDA5 and HA-tagged phosphatase constructs, were used for IP with Flag antibody and for subsequent
IB with pS88-MDA5 or Flag antibodies.
(B and C) HEK293T cells were transfected with GST-MDA5(2CARD) (B) or GST-RIG-I(2CARD) (C) together with control siRNA (siC) or siRNA specific to PP1a or
PP1g. WCLs were subjected to GST-PD, followed by IB with the indicated antibodies.
(D) HEK293T cells were transfected with vector or Flag-MDA5. At 45 hr after transfection, cells were mock treated or infected with EMCV (MOI 0.5) for 3 hr. WCLs
were subjected to IP with Flag antibody.
(E and F) HEK293T cells (E) or normal human lung fibroblasts (NHLFs) (F) were either mock treated, infected with SeV (50 HAU/ml) for 18 hr (E), or infected with
DNS1 A/PR/8/34 influenza virus (MOI 2) for the indicated time points (F). WCLs were subjected to IP with RIG-I antibody. The following abbreviation is used: n.s.,
nonspecific band.
(G andH) HEK293T cells (G) or NHLFs (H) cells were either mock treated, transfected with poly(I:C) for 36 hr (G), or infected with EMCV (MOI 0.5) for 3 hr (H). WCLs
were subjected to IP with MDA5 antibody.
See also Figures S3 and S4.
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Activation of RIG-I and MDA5 Signaling by PP1N-terminal CARDs. To test this, we investigated the effect of
silencing PP1a or PP1g on downstream signaling triggered by
the 2CARD of RIG-I or by Sendai virus (SeV), known to activate
RIG-I. Silencing of IRF3 served as a control (Figures 3F and
3G). This showed that siRNA-mediated depletion of endogenous
PP1a or PP1g, but not PP1b, strongly decreased the RIG-
I(2CARD)- and SeV-induced IFN-b promoter activation (Figures
3F and 3G). In summary, these results suggest that the phospha-
tases PP1a and PP1g are important regulators of the CARD-
mediated signal transduction of both MDA5 and RIG-I.
PP1a and PP1g Interact with MDA5 and RIG-I upon Virus
Infection, Leading to Their Dephosphorylation
We next addressed whether PP1a and PP1g specifically
dephosphorylate S88 in MDA5 and the S8 and T170 residues
in RIG-I. Exogenous PP1a or PP1g substantially decreased442 Immunity 38, 437–449, March 21, 2013 ª2013 Elsevier Inc.the S88 phosphorylation of Flag-MDA5, but neither PP1b nor
any of the other candidate phosphatases found in our siRNA
screen had any effect (Figure 4A and Figure S3A). Crucially,
specific gene silencing of PP1a and PP1g strongly enhanced
the S88 phosphorylation of MDA5(2CARD) (Figure 4B). The
effect of PP1a and PP1g depletion on the S88 phosphoryla-
tion of MDA5 was specific, given that PP1 depletion did
not have any effect on MDA5 S104 phosphorylation levels
(Figure S3B). Accordingly, ectopically expressed PP1a and
PP1g, but neither PP1b nor any of the other candidate phos-
phatases from our siRNA screen, led to a strong decrease
in RIG-I CARD phosphorylation (Figures S3C and S3D).
Inversely, compared to transfection of nontargeting control
siRNA, depletion of PP1a and PP1g profoundly enhanced
the S8 and T170 phosphorylation of GST-RIG-I(2CARD)
(Figure 4C).
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Activation of RIG-I and MDA5 Signaling by PP1We next tested the interaction between MDA5 and PP1a or
PP1g. Consistent with their abilities to induce antiviral signaling
independently of viral stimulation, exogenously expressed Flag-
MDA5 and GST-MDA5(2CARD) efficiently interacted with PP1a
and PP1g in mock-infected cells (Figure 4D and Figure S4A).
Furthermore, EMCV infection further enhanced the binding of
PP1a and PP1g to Flag-MDA5 (Figure 4D). In contrast, PP1b
did not bind Flag-MDA5 or GST-MDA5(2CARD) under these
conditions (Figure 4D and Figure S4A). Moreover, RIG-I(2CARD)
and MDA5(2CARD), but not a RIG-I or MDA5 mutant in which
the 2CARD had been deleted (RIG-I or MDA5 D2CARD), readily
interacted with endogenous PP1a and PP1g (Figure S4B).
Next, we sought to explore the molecular details of how virus
infection leads to RIG-I and MDA5 dephosphorylation by PP1
and thereby induces antiviral signal transduction. We first
assessed the endogenous protein levels of PP1a, PP1g, and
RIG-I under normal conditions or in cells either infected with
SeV or treated with IFN-b by immunoblot analysis (Figure S4C).
Consistent with previous reports, endogenous RIG-I levels
were low under normal conditions but markedly increased
upon SeV infection or IFN-b stimulation. In contrast, the protein
expression of endogenous PP1a and PP1g was readily detect-
able in mock-treated cells and did not change upon IFN-b treat-
ment or virus infection (Figure S4C). To investigate whether virus
infection regulates the specific recruitment of PP1a and PP1g to
RIG-I and MDA5, we examined PP1a and PP1g binding to
endogenous RIG-I in HEK293T cells prior to and after SeV infec-
tion by coimmunoprecipitation (Figure 4E). PP1a and PP1g
specifically bound to RIG-I in cells infected with SeV, whereas
no interaction was detected in uninfected cells (Figure 4E).
Consistently, endogenous PP1a andPP1g exclusively interacted
with RIG-I in primary normal human lung fibroblasts (NHLFs) that
had been infected with DNS1 influenza virus, but not in mock-
treated cells (Figure 4F). Accordingly, PP1a and PP1g were
detected in complex with endogenous MDA5 exclusively in
poly(I:C)-transfected or EMCV-infected cells, but not in mock-
treated cells (Figures 4G and 4H). Crucially, endogenous RIG-I
and MDA5 that interacted with PP1 exhibited markedly
decreased phosphorylation levels at S8 and S88, respectively
(Figures 4F and 4H). To provide further evidence of the specific
recruitment of PP1 to RIG-I and MDA5 upon virus infection or
dsRNA stimulation, we employed confocal microscopy. To this
end, HeLa cells were mock-treated, infected with SeV to
activate RIG-I, or transfected with poly(I:C) to stimulate MDA5;
this was followed by determining the localization of endogenous
RIG-I orMDA5, aswell as PP1a andPP1g (Figures S4DandS4E).
Whereas cytoplasmic RIG-I and MDA5 expression was low in
uninfected cells and increased upon SeV infection or poly(I:C)
transfection, robust PP1a and PP1g expression was detected
in mock-treated and infected or stimulated cells in both the
nucleus and the cytoplasm. Furthermore, PP1a and PP1g exten-
sively colocalized with endogenous RIG-I in the cytoplasm,
specifically in SeV-infected cells, but not in uninfected cells (Fig-
ure S4D). Similar to that with RIG-I, extensive colocalization of
PP1 with endogenous MDA5 was observed exclusively upon
poly(I:C)-stimulation (Figure S4E). Collectively, these results indi-
cate that PP1a and PP1g are recruited to RIG-I and MDA5 upon
virus infection or viral RNA binding and that this recruitment
leads to their dephosphorylation and hence activation.Enhanced Phosphorylation and Abolished Signaling
Activity of PP1-Binding-Deficient Mutants of MDA5
and RIG-I
Several known PP1-binding motifs have been identified in
PP1 substrates or PP1-binding proteins, and they include the
canonical R/K-x(0,1)-V/I-x-F/W motif (commonly termed the
RVxF motif) and the more recently discovered F-x-x-R/K-x-
R/K motif (Garcia et al., 2004; Roy and Cyert, 2009). Indeed,
RIG-I and MDA5 harbor an F-x-x-R/K-x-R/K consensus motif
(referred to as motif I [MI]) in their N-terminal CARDs and an
RVxF motif (referred to as motif II [MII]) in their helicase domain
(Figure 5A, upper panel). To corroborate the role of PP1 in RIG-I
and MDA5 dephosphorylation-mediated activation, we re-
placed hydrophobic and basic residues in the PP1-binding
motif I or II of MDA5 and RIG-I with alanine; we then tested
these mutants for their signal-transducing abilities in an IFN-b
promoter assay (Figure 5A, lower panel; Figure S5A). Strikingly,
mutating PP1-binding motif MI or MII in MDA5 and motif MI in
RIG-I caused a near-complete loss of signal-transducing
activity, whereas mutation of motif MII in RIG-I did not affect
RIG-I signaling ability (Figure 5A, lower panel). Furthermore,
MDA5 mutants MI and MII and RIG-I mutant MI exhibited an
abolished PP1-binding ability and, consistent with this, much
higher S88 or S8 phosphorylation levels than those of WT
MDA5 or RIG-I (Figures 5B and 5C). In contrast, the RIG-I
mutant MII exhibited comparable PP1-binding activity and S8
phosphorylation levels to those of WT RIG-I. Notably, when
tested for their RNA-binding ability, PP1-binding mutants MI
and MII of RIG-I and MDA5 bound as efficiently as WT RIG-I
or MDA5 to in-vitro-transcribed 50 triphosphate rabies virus
leader RNA and poly(I:C), respectively (Figure S5B). We next
complemented Mda5-deficient (Ifih1/) and Rig-I-deficient
(Ddx58/) MEFs with the PP1-binding mutant MI or MII of
MDA5 and RIG-I, respectively (Figure 5D). MEFs com-
plemented with WT MDA5 or WT RIG-I served as controls.
Poly(I:C)-induced IFN-b production was higher in Ifih1/
MEFs reconstituted with WT MDA5 than in Ifih1/ MEFs ex-
pressing the vector or the MDA5 mutants MI or MII (Figure 5D,
left panel). Moreover, SeV infection triggered a robust IFN-b
production in Ddx58/ MEFs complemented with Flag-tagged
WT RIG-I or RIG-I mutant MII, whereas no IFN-b was detected
in SeV-infected cells complemented with the PP1-binding-
deficient mutant MI of RIG-I (Figure 5D, right panel). Because
our previous work indicated that RIG-I S8 and T170 phosphor-
ylation inhibits RIG-I CARD ubiquitination (Gack et al., 2010;
Nistal-Villa´n et al., 2010), we tested the phosphorylation and
ubiquitination levels, as well as signal-transducing abilities, of
WT GST-RIG-I(2CARD) and the PP1-binding-deficient mutant
MI (Figures 5E and 5F). Compared to WT RIG-I(2CARD),
GST-RIG-I(2CARD) MI exhibited strongly enhanced S8 phos-
phorylation levels and, correlated with this, abolished CARD
ubiquitination (Figure 5E). Furthermore, whereas WT GST-
RIG-I(2CARD) robustly activated the IFN-b promoter, RIG-
I(2CARD) MI did not have any signaling activity (Figure 5F).
These results indicate that PP1 binding and PP1-dependent
dephosphorylation of RIG-I and MDA5 are critical for their
IFN-inducing activities in response to virus infection. In the
case of RIG-I, dephosphorylation by PP1 is critical for RIG-I






Figure 5. PP1-Binding-Deficient Mutants of RIG-I and MDA5 Exhibit Enhanced CARD Phosphorylation Levels and Abolished Downstream
Signaling Abilities
(A) In the upper panel are the identified PP1-binding motifs in MDA5 and RIG-I. In the lower panel, Flag-tagged WT or mutant MDA5 (left panel) or WT or mutant
RIG-I (right panel) together with IFN-b luciferase and pGK-b-gal were transfected into HEK293T cells. Luciferase and b-gal activities were measured 48 hr later.
The results are expressed as means ± SD (n = 3).
(B) HEK293T cells were transfected with vector, Flag-MDA5, Flag-RIG-I, or the indicated mutants together with HA-tagged PP1a or PP1g and were then infected
with EMCV (MOI 0.5) (left panel) or SeV (50 HAU/ml) (right panel) for 3 hr. WCLs were used for IP with Flag antibody.
(C) WCLs of HEK293T cells transfected with Flag-MDA5, Flag-RIG-I, or the indicated mutants were used for IP with Flag antibody.
(D) Ifih1/ and Ddx58/ MEFs were complemented with WT or mutant MDA5 and WT or mutant RIG-I, respectively. IFN-b production upon mock treatment,
poly(I:C) (0.1 mg/ml) transfection (left), or SeV infection (50 HAU/ml) (right) was determined by ELISA. The results are expressed as means ± SD (n = 3). The
following abbreviation is used: ND, not detectable.
(E) WCLs of HEK293T cells transfected with WT or MI mutant GST-RIG-I(2CARD) were subjected to GST-PD. Arrows indicate ubiquitinated bands.
(F) HEK293T cells were transfected with GST, WT GST-RIG-I(2CARD), or the GST-RIG-I(2CARD) MI mutant together with IFN-b luciferase and pGK-b-gal.
Luciferase and b-gal activities were determined 48 hr after transfection. The results are expressed as means ± SD (n = 3).
See also Figure S5.
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Activation of RIG-I and MDA5 Signaling by PP1PP1a and PP1g Are Critical for the IFN-Mediated
Antiviral Activity of RIG-I and MDA5 in Response to VSV
and EMCV
To determine the physiological role of PP1 in regulating type I IFN
production induced by RIG-I and MDA5, we silenced endoge-
nous PP1a and PP1g in primary NHLFs and examined the
production of IFN-b upon transfection of poly(I:C) or EMCV-444 Immunity 38, 437–449, March 21, 2013 ª2013 Elsevier Inc.RNA, both of which stimulate MDA5, or upon infection with
SeV or DNS1 influenza A virus, both of which are sensed by
RIG-I (Figure 6A). Depletion of PP1a and PP1g significantly
decreased the IFN-b production induced by viral RNA or by viral
infection (Figure 6A). To determine the individual contribution of
PP1a and PP1g to MDA5 and RIG-I dephosphorylation and
antiviral signaling, we examined the effect of silencing PP1a,
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Figure 6. Depletion of PP1a and PP1g Decreases Antiviral IFN Production and Enhances Viral Replication
(A) NHLFs were transfected with the indicated siRNAs. Cells were either mock transfected, transfected with poly(I:C) or Vero-EMCV-RNA, or infected with DNS1
A/PR/8/34 influenza virus or SeV 48 hr later. IFN-b production was measured by ELISA 24 hr later. PP1 knockdown was confirmed by IB. The results are
expressed as means ± SD (n = 3). *p < 0.05; **p < 0.005. The following abbreviation is used: ND, not detectable.
(B and C) NHLFs were transfected with the indicated siRNAs. Cells were infected with VSV-EGFP (MOI 0.05) 48 hr later. EGFP expression was determined by
microscopy (B) and IB (C) and virus titers were determined by plaque assay (B) 24 hr after infection. PP1 knockdown was confirmed by IB (C). The following
abbreviation is used: Pfu, plaque-forming unit.
(D and E) THP-1 cells were transfected with control siRNA (siC) or with PP1a- and PP1g-specific siRNAs and were then mock infected or infected with EMCV
(MOI 1) for 5 hr. Total RNA was isolated and subjected to RT-PCR using gene-specific primers for ISG15, ISG54, and ISG56 (D). PP1 knockdown was confirmed
by IB (E).
See also Figure S6.
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Activation of RIG-I and MDA5 Signaling by PP1PP1g, or both on IFN-b production and on MDA5 or RIG-I CARD
phosphorylation (Figure S6).Whereas depletion of either PP1a or
PP1gmarkedly decreased the poly(I:C)- and SeV-induced IFN-b
production, silencing of both PP1a and PP1g reduced the IFN-b
levels even further (Figures S6A and S6B). Consistently, deple-
tion of either PP1a or PP1g detectably enhanced MDA5 S88
and RIG-I S8 phosphorylation, and these phosphorylations
were further increased in PP1a and PP1g doubly depleted cells
(Figures S6C and S6D). These results suggest that both PP1a
and PP1g, which share 90% identity at the amino acid level,
contribute to RIG-I and MDA5 dephosphorylation-dependentactivation in these cells. We next addressed whether PP1a and
PP1g specifically regulate the signaling activity of RIG-I-like
receptors (RLRs). To this end, we tested the effect of silencing
PP1a and PP1g on the signal transduction induced by Toll-like
receptor 3 (TLR3) (Figure S7A). This showed that PP1a and
PP1g depletion did not have any effect on TLR3-induced
NF-lB promoter activation upon poly(I:C) stimulation, sug-
gesting that PP1 specifically regulates RLR signaling, but not
TLR3 signal transduction.
To examine the functional role of PP1a and PP1g in regu-
lating the antiviral activity of RIG-I and MDA5, we examinedImmunity 38, 437–449, March 21, 2013 ª2013 Elsevier Inc. 445
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Activation of RIG-I and MDA5 Signaling by PP1virus replication or the induction of IFN-stimulated genes (ISGs)
by viruses known to activate RIG-I (vesicular stomatitis virus
[VSV]) or MDA5 (EMCV) in cells in which PP1a and PP1g had
been silenced (Figures 6B–6E). Compared to transfection of
nontargeting control siRNA, depletion of endogenous PP1a
and PP1g in primary NHLFs substantially enhanced the replica-
tion of VSV-EGFP, as determined by fluorescence microscopy,
plaque assay, and anti-EGFP immunoblotting (Figures 6B and
6C). Efficient depletion of PP1a and PP1g was confirmed by
immunoblot (Figure 6C). Furthermore, PP1a and PP1g doubly
depleted THP-1 macrophages had markedly lower ISG tran-
script amounts upon EMCV infection than did cells transfected
with nontargeting control siRNA (Figures 6D and 6E).
PP1a and PP1g Are Critical for IFN-Mediated Inhibition
of DenV Replication
Because our results indicated that PP1a and PP1g are common
activators of both RIG-I and MDA5, we next explored the effects
of PP1a or PP1g overexpression and gene silencing on the repli-
cation of DenV, a virus detected by both RIG-I and MDA5
(Figures 7A and 7B). This showed that compared to vector trans-
fection, expression of increasing amounts of PP1a or PP1g
strongly suppressed DenV replication in a dose-dependent
manner (Figure 7A). To complement these gain-of-function
assays, we depleted PP1a and PP1g in HeLa cells and then in-
fected them with DenV (Figure 7B). DenV replication in cells in
which PP1a and PP1g had been silenced was more than
7-fold greater than that in cells transfected with nontargeting
siRNA (Figure 7B). Furthermore, PP1a and PP1g readily inter-
acted with endogenous MDA5 and RIG-I in DenV-infected, but
not uninfected, cells, and this correlated with enhanced IRF3
phosphorylation at S396, a marker of activation of the RLR
signaling pathway (Figures 7C and 7D). Consistent with our
data showing that PP1 is critical for RIG-I- and MDA5-mediated
IFN-b induction, the enhanced DenV replication in PP1a and
PP1g doubly depleted cells (compared to cells transfected
with control siRNA) directly correlated with markedly reduced
ISG protein expression after DenV infection (Figure 7E). Taken
together, these results indicate that the dephosphorylation of
RIG-I and MDA5 by PP1a and PP1g is essential for these
sensors to elicit immune signaling for the control of RNA virus
infections.
DISCUSSION
The role of kinases, such as IKK-ε, TBK1, and RIP1, in activating
immune responses to viral infection has long been established
(Lee and Kim, 2007); in contrast, the impact of phosphatases
in antiviral signaling pathways is largely undetermined. Here,
we have provided evidence demonstrating that the phospha-
tases PP1a and PP1g are essential for an effective antiviral
innate immune response mediated by the cytosolic pattern-
recognition receptors RIG-I and MDA5.
Using mass spectrometry and phosphorylation-state-specific
antibodies, we found that theCARDs ofMDA5 are robustly phos-
phorylated in uninfected cells. Mutational analyses further indi-
cated that phosphorylation ofMDA5 at S88 keeps it in an inactive
state. Combined with our previous studies on RIG-I (Gack et al.,
2010; Maharaj et al., 2012; Nistal-Villa´n et al., 2010), this corrob-446 Immunity 38, 437–449, March 21, 2013 ª2013 Elsevier Inc.orates that constitutive Ser-Thr phosphorylation is a common
mechanism for suppressing the signal-transducing activity of
RIG-I and MDA5 and for preventing premature IFN production
prior to virus infection. Moreover, our study shows that upon
virus infection or stimulation by dsRNA, the MDA5 CARDs, as
seen with RIG-I, are rapidly dephosphorylated—a process
necessary for the initiation of downstream signaling—and
thereby trigger antiviral innate immune responses. For the cyto-
solic sensors RIG-I andMDA5, our study thus establishes a regu-
lation concept that is characterized by a dynamic balance
between constitutive phosphorylation for their inactivation and
stimulus-dependent dephosphorylation, which triggers RLR
activation upon virus infection.
The central finding of this study—that the phosphatases PP1a
and PP1g are key regulators of RIG-I and MDA5 antiviral
signaling—was established with a complementary set of overex-
pression and siRNA gene-targeting studies that measured IFN-b
production, ISG protein and mRNA levels, or virus replication
upon infection with viruses belonging to five different families,
paramyxoviruses (SeV), rhabdoviruses (VSV), orthomyxoviruses
(influenza virus), picornaviruses (EMCV), and flaviviruses (DenV).
In each of these assays, we found that PP1a and PP1g are crit-
ical regulators of RIG-I- and MDA5-mediated antiviral IFN
production and thereby suppress viral replication. Furthermore,
the identification of PP1-binding motifs in RIG-I and MDA5, as
well as the functional characterization of PP1-binding-deficient
mutants of both sensors, provided genetic evidence that PP1
plays a crucial role in RLR signaling.
PP1 is a major eukaryotic Ser-Thr phosphatase implicated in
a large variety of dephosphorylation events catalyzed by one
of its three catalytic subunits (PP1a, PP1b, and PP1g). Our study
demonstrates that PP1a and PP1g are crucial for eliciting an
antiviral innate immune response by inducing dephosphorylation
of the CARDs of RIG-I and MDA5 and thus allowing MAVS-
dependent downstream signaling. Our study further reveals
some of the details of how virus infection triggers RIG-I and
MDA5 dephosphorylation by PP1. In contrast to RIG-I and
MDA5 expression levels, PP1a and PP1g expression levels
were stable and did not change upon virus infection or dsRNA
stimulation. Moreover, our study shows that PP1a and PP1g
are in complex with RIG-I or MDA5 exclusively in virus-infected
or dsRNA-stimulated cells, but not in uninfected cells, sug-
gesting that the specific recruitment of PP1 to these sensors
triggers the rapid dephosphorylation of their CARDs upon virus
infection. In addition, it has been recently shown that Ser-Thr
phosphorylation of the RIG-I CTD also suppresses RIG-I down-
stream signaling (Sun et al., 2011). It will thus be interesting to
investigate whether PP1 also dephosphorylates the CTD and
thereby leads to RIG-I activation. Furthermore, our data show
that in addition to strongly enhancing the IFN-b promoter activa-
tion induced by WT MDA5, exogenous PP1g also enhanced
signaling induced by the MDA5 S88A mutant, albeit to a lesser
extent (40% of the effect seen with WT MDA5) (data not
shown), suggesting that there are additional phosphorylation
sites dephosphorylated by PP1 in the MDA5 C-terminal region.
Moreover, it is well established that the complex formation of
the PP1 catalytic subunit with different regulatory subunits can
determine its substrate specificity or subcellular location (Cohen,
2002). Thus, the potential regulation of PP1’s enzymatic activity
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Figure 7. PP1a and PP1g Are Critical for ISG Induction and Host Antiviral Activity to DenV
(A) HEK293T cells were infected with DenV (MOI 0.5) 30 hr after transfection with vector, PP1a, or PP1g. Cells were stained for viral envelope protein (red) 42 hr
later. Nuclei were stained with DAPI (blue). Quantification of infection is presented as relative infection compared to that of the control. The results are expressed
as means ± SD (n = 3). *p < 0.05; **p < 0.005.
(B) HeLa cells were infected with DenV (MOI 0.01) 48 hr after transfection with the indicated siRNAs. Cells were stained for viral envelope protein (red) 42 hr later.
Nuclei were stained with DAPI (blue). Quantification of infection is presented as relative infection compared to that of the control. The results are expressed as
means ± SD (n = 3). **p < 0.005.
(C and D) NHLFs were either mock treated or infected with DenV (MOI 0.1) for the indicated time points. WCLs were used for IP with MDA5 (C) or RIG-I (D)
antibody.
(E) NHLFs were transfected with the indicated siRNAs. After 48 hr, cells were either mock infected or infected with DenV (MOI 0.25) for 24 hr. WCLs were
subjected to IB with the indicated antibodies.
See also Figure S7.
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Activation of RIG-I and MDA5 Signaling by PP1or its recruitment to RIG-I and MDA5 by specific regulatory
subunits remains ground for future studies.
Our findings, combined with previous studies and the recently
solved crystal structure of RIG-I (Jiang et al., 2011; Kowalinski
et al., 2011; Luo et al., 2011), support the following model of
RLR activation (Figure S7B): under normal conditions, RIG-I is
kept inactive by a closed conformation, where the CARD2 inter-
acts with the helicase and possibly CTD and where the tandem
CARD forms a head-to-tail conformation characterized by aninteraction between the N terminus of CARD2 and theC terminus
of CARD1. Our data show that constitutive phosphorylation of
the CARDs of both RIG-I and MDA5 prevents premature down-
stream signaling, possibly by keeping the tandem CARD in its
inactive head-to-tail conformation, and we have recently shown
that conventional protein kinase C interacts with RIG-I and
phosphorylates its CARDs. (Maharaj et al., 2012). The first step
of RIG-I and MDA5 activation is binding of 50-triphosphate-
containing dsRNA and long dsRNA, respectively, first to theImmunity 38, 437–449, March 21, 2013 ª2013 Elsevier Inc. 447
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Activation of RIG-I and MDA5 Signaling by PP1CTD and subsequently to the helicase domain. For RIG-I, viral
RNA binding is believed to trigger a conformational change
and lead to ATP hydrolysis and release of the CARDs. The
data presented here indicate that the exposed CARDs then allow
recruitment of PP1a and PP1g, which then rapidly dephosphor-
ylate S8 and T170 of RIG-I and S88 of MDA5. CARD dephos-
phorylation is likely to lead to a structural change within the
tandem CARD. In the case of RIG-I, dephosphorylation of S8
and T170 allows binding of TRIM25 to CARD1 (Gack et al.,
2010; Nistal-Villa´n et al., 2010), which induces K63-linked ubiq-
uitination or unanchored polyubiquitin binding of CARD2 (Gack
et al., 2007; Zeng et al., 2010). Future studies will be directed
toward elucidating themolecular mechanisms bywhich dephos-
phorylation of S88 in MDA5 triggers MAVS binding and whether
MDA5 phosphorylation regulates other MDA5 posttranslational
modifications, including free ubiquitin binding, as recently re-
ported (Jiang et al., 2012).
In summary, our results provide insights into the complex
regulatory network of the RIG-I and MDA5 signaling pathway
and identify PP1a and PP1g as molecules to be exploited




HEK293T cells, HeLa cells, Vero cells, NHLFs, and MEFs were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum (FBS), 2 mM L-glutamine, and 1% penicillin-streptomycin
(GIBCO-BRL). HEK293T cells stably expressing TLR3 (Imgenex) were cultured
in complete DMEM containing 10 mg/ml blasticidin (Invitrogen). THP-1
cells (ATCC) were cultured in RPMI supplemented with 10% FBS, 2 mM
L-glutamine, 0.05 mM 2-mercaptoethanol, 1 mM sodium pyruvate, and 1%
penicillin-streptomycin.
WT and Mda5-deficient MEFs were isolated from WT and Mda5-deficient
(Ifih1/) mice (kindly provided by M. Colonna from Washington University),
respectively (Gitlin et al., 2010). Experimental protocols involving animals
were approved by the University of Massachusetts Medical School
Institutional Animal Care and Use Committee. Isolated MEFs were immortal-
ized with LXSN-E6/E7 retroviral vector containing human papilloma virus
16 E6 and E7 oncogenes according to a standard protocol of selection with
200 mg/ml neomycin. Immortalized Rig-I-deficient (Ddx58/) MEFs were
described previously (Gack et al., 2007).
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and can be found with this
article online at http://dx.doi.org/10.1016/j.immuni.2012.11.018.
ACKNOWLEDGMENTS
This work was supported by United States Public Health Service grants R01
AI087846, R21 AI097699, and RR00168 (M.U.G.) and by the German
Research Foundation (E.W.). We greatly thank J. Jung, L. Gehrke, S. Whelan,
M. Colonna, and A. Garcı´a-Sastre for providing reagents and R. Tomaino for
mass spectrometry. E. Wies and M. Wang performed the majority of the ex-
periments. M. Gack performed experiments and analyzed data. N. Maharaj
and K. Chen performed experiments and assisted in data collection. S. Zhou
and R. Finberg provided Mda5-deficient MEFs. M. Gack organized this
study and wrote the paper.
Received: June 19, 2012
Accepted: November 7, 2012
Published: March 14, 2013448 Immunity 38, 437–449, March 21, 2013 ª2013 Elsevier Inc.REFERENCES
Aebersold, R., and Goodlett, D.R. (2001). Mass spectrometry in proteomics.
Chem. Rev. 101, 269–295.
Andrejeva, J., Childs, K.S., Young, D.F., Carlos, T.S., Stock, N., Goodbourn,
S., and Randall, R.E. (2004). The V proteins of paramyxoviruses bind the
IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta
promoter. Proc. Natl. Acad. Sci. USA 101, 17264–17269.
Arimoto, K., Takahashi, H., Hishiki, T., Konishi, H., Fujita, T., and Shimotohno,
K. (2007). Negative regulation of the RIG-I signaling by the ubiquitin ligase
RNF125. Proc. Natl. Acad. Sci. USA 104, 7500–7505.
Barbalat, R., Ewald, S.E., Mouchess, M.L., and Barton, G.M. (2011). Nucleic
acid recognition by the innate immune system. Annu. Rev. Immunol. 29,
185–214.
Cohen, P.T. (2002). Protein phosphatase 1—targeted in many directions.
J. Cell Sci. 115, 241–256.
Gack, M.U., Shin, Y.C., Joo, C.H., Urano, T., Liang, C., Sun, L., Takeuchi, O.,
Akira, S., Chen, Z., Inoue, S., and Jung, J.U. (2007). TRIM25 RING-finger E3
ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446,
916–920.
Gack, M.U., Kirchhofer, A., Shin, Y.C., Inn, K.S., Liang, C., Cui, S., Myong, S.,
Ha, T., Hopfner, K.P., and Jung, J.U. (2008). Roles of RIG-I N-terminal tandem
CARD and splice variant in TRIM25-mediated antiviral signal transduction.
Proc. Natl. Acad. Sci. USA 105, 16743–16748.
Gack, M.U., Albrecht, R.A., Urano, T., Inn, K.S., Huang, I.C., Carnero, E.,
Farzan, M., Inoue, S., Jung, J.U., and Garcı´a-Sastre, A. (2009). Influenza A
virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the
host viral RNA sensor RIG-I. Cell Host Microbe 5, 439–449.
Gack, M.U., Nistal-Villa´n, E., Inn, K.S., Garcı´a-Sastre, A., and Jung, J.U.
(2010). Phosphorylation-mediated negative regulation of RIG-I antiviral
activity. J. Virol. 84, 3220–3229.
Garcia, A., Cayla, X., Caudron, B., Deveaud, E., Roncal, F., and Rebollo, A.
(2004). New insights in protein phosphorylation: a signature for protein phos-
phatase 1 interacting proteins. C. R. Biol. 327, 93–97.
Gitlin, L., Benoit, L., Song, C., Cella, M., Gilfillan, S., Holtzman, M.J., and
Colonna, M. (2010). Melanoma differentiation-associated gene 5 (MDA5) is
involved in the innate immune response to Paramyxoviridae infection in vivo.
PLoS Pathog. 6, e1000734.
Honda, K., Takaoka, A., and Taniguchi, T. (2006). Type I interferon [corrected]
gene induction by the interferon regulatory factor family of transcription
factors. Immunity 25, 349–360.
Jiang, F., Ramanathan, A., Miller, M.T., Tang, G.Q., Gale, M., Jr., Patel, S.S.,
and Marcotrigiano, J. (2011). Structural basis of RNA recognition and activa-
tion by innate immune receptor RIG-I. Nature 479, 423–427.
Jiang, X., Kinch, L.N., Brautigam, C.A., Chen, X., Du, F., Grishin, N.V., and
Chen, Z.J. (2012). Ubiquitin-induced oligomerization of the RNA sensors
RIG-I and MDA5 activates antiviral innate immune response. Immunity 36,
959–973.
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K.,
Uematsu, S., Jung, A., Kawai, T., Ishii, K.J., et al. (2006). Differential roles of
MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441,
101–105.
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K.J.,
Takeuchi, O., and Akira, S. (2005). IPS-1, an adaptor triggering RIG-I- and
Mda5-mediated type I interferon induction. Nat. Immunol. 6, 981–988.
Kowalinski, E., Lunardi, T., McCarthy, A.A., Louber, J., Brunel, J., Grigorov, B.,
Gerlier, D., and Cusack, S. (2011). Structural basis for the activation of innate
immune pattern-recognition receptor RIG-I by viral RNA. Cell 147, 423–435.
Lee, M.S., and Kim, Y.J. (2007). Signaling pathways downstream of pattern-
recognition receptors and their cross talk. Annu. Rev. Biochem. 76, 447–480.
Loo, Y.M., and Gale, M., Jr. (2011). Immune signaling by RIG-I-like receptors.
Immunity 34, 680–692.
Loo, Y.M., Fornek, J., Crochet, N., Bajwa, G., Perwitasari, O., Martinez-
Sobrido, L., Akira, S., Gill, M.A., Garcı´a-Sastre, A., Katze, M.G., and Gale,
Immunity
Activation of RIG-I and MDA5 Signaling by PP1M., Jr. (2008). Distinct RIG-I and MDA5 signaling by RNA viruses in innate
immunity. J. Virol. 82, 335–345.
Luo, D., Ding, S.C., Vela, A., Kohlway, A., Lindenbach, B.D., and Pyle, A.M.
(2011). Structural insights into RNA recognition by RIG-I. Cell 147, 409–422.
Maharaj, N.P., Wies, E., Stoll, A., and Gack, M.U. (2012). Conventional protein
kinase C-a (PKC-a) and PKC-b negatively regulate RIG-I antiviral signal trans-
duction. J. Virol. 86, 1358–1371.
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M.,
Bartenschlager, R., and Tschopp, J. (2005). Cardif is an adaptor protein in
the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437,
1167–1172.
Meylan, E., Tschopp, J., and Karin, M. (2006). Intracellular pattern recognition
receptors in the host response. Nature 442, 39–44.
Nakhaei, P., Genin, P., Civas, A., and Hiscott, J. (2009). RIG-I-like receptors:
sensing and responding to RNA virus infection. Semin. Immunol. 21, 215–222.
Nistal-Villa´n, E., Gack, M.U., Martı´nez-Delgado, G., Maharaj, N.P., Inn, K.S.,
Yang, H., Wang, R., Aggarwal, A.K., Jung, J.U., and Garcı´a-Sastre, A.
(2010). Negative role of RIG-I serine 8 phosphorylation in the regulation of inter-
feron-beta production. J. Biol. Chem. 285, 20252–20261.
Oshiumi, H., Matsumoto, M., Hatakeyama, S., and Seya, T. (2009). Riplet/
RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-
beta induction during the early phase of viral infection. J. Biol. Chem. 284,
807–817.Roy, J., and Cyert, M.S. (2009). Cracking the phosphatase code: docking inter-
actions determine substrate specificity. Sci. Signal. 2, re9.
Saito, T., Hirai, R., Loo, Y.M., Owen, D., Johnson, C.L., Sinha, S.C., Akira, S.,
Fujita, T., and Gale, M., Jr. (2007). Regulation of innate antiviral defenses
through a shared repressor domain in RIG-I and LGP2. Proc. Natl. Acad.
Sci. USA 104, 582–587.
Seth, R.B., Sun, L., Ea, C.K., and Chen, Z.J. (2005). Identification and charac-
terization of MAVS, a mitochondrial antiviral signaling protein that activates
NF-kappaB and IRF 3. Cell 122, 669–682.
Sumpter, R., Jr., Loo, Y.M., Foy, E., Li, K., Yoneyama, M., Fujita, T., Lemon,
S.M., and Gale, M., Jr. (2005). Regulating intracellular antiviral defense and
permissiveness to hepatitis C virus RNA replication through a cellular RNA heli-
case, RIG-I. J. Virol. 79, 2689–2699.
Sun, Z., Ren, H., Liu, Y., Teeling, J.L., and Gu, J. (2011). Phosphorylation
of RIG-I by casein kinase II inhibits its antiviral response. J. Virol. 85,
1036–1047.
Xu, L.G., Wang, Y.Y., Han, K.J., Li, L.Y., Zhai, Z., and Shu, H.B. (2005). VISA is
an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19,
727–740.
Zeng, W., Sun, L., Jiang, X., Chen, X., Hou, F., Adhikari, A., Xu, M., and Chen,
Z.J. (2010). Reconstitution of the RIG-I pathway reveals a signaling role of
unanchored polyubiquitin chains in innate immunity. Cell 141, 315–330.Immunity 38, 437–449, March 21, 2013 ª2013 Elsevier Inc. 449
